Novel compound antihypertensive preparation

A compound preparation and high blood pressure technology, which is applied in the field of medicine, can solve problems such as inaccurate clinical dosage, influence on drug efficacy, and increased side effects, and achieve the effect of improving antihypertensive efficacy, less adverse reactions, and good antihypertensive effect
CN101757004AInactive Publication Date: 2010-06-30JIANGSU JIBEIER PHARMA
0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN · China
Current Assignee / Owner
JIANGSU JIBEIER PHARMA
Publication Date
2010-06-30
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
Patent Text Reader

Abstract

The invention discloses a novel compound antihypertensive preparation which comprises 50-200mg of irbesartan and 5-30mg of fosinopril. Aiming at solving the problem that currently when only one of irbesartan and fosinopril is used clinically, in order to ensure the curative effect, the dosage of the drug is increased, which leads to obvious increase of the side effects, the invention provides a novel compound preparation. Irbesartan and fosinopril are used together, so synergic and complementary curative effect can be produced. The novel compound antihypertensive preparation enhances the tolerance of the patient, improves the compliance and reduces the dosage and the adverse reaction, and is convenient to take and cheap in price.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention relates to the technical field of medicine and discloses a new compound antihypertensive preparation. Background technique

[0002] Hypertension is the most common cardiovascular disease and a major public health problem worldwide. my country currently has about 100 million hypertensive patients. According to the epidemiological survey in 1991, the awareness rate of hypertension in my country's urban and rural areas was 36% and 13%, and the treatment rate was 17% and 5%, respectively. The form of hypertension prevention and treatment is quite severe. According to the forecast of WTO, by 2020, non-communicable diseases will account for 79% of the causes of death in my country, among which cardiovascular diseases will take the first place.

[0003] Commonly used antihypertensive drugs include the angiotensin receptor antagonist irbesartan and the angiotensin converting enzyme inhibitor fosinopril.

[0004] Irbesartan (Irbesartan), the ch...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More